APA (7th ed.) Citation

Räber, L., Ueki, Y., Otsuka, T., Losdat, S., Häner, J. D., Lonborg, J., . . . Koskinas, K. C. (2022). Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial. JAMA : the journal of the American Medical Association, 327(18), 1771. https://doi.org/10.1001/jama.2022.5218

Chicago Style (17th ed.) Citation

Räber, Lorenz, et al. "Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial." JAMA : The Journal of the American Medical Association 327, no. 18 (2022): 1771. https://doi.org/10.1001/jama.2022.5218.

MLA (9th ed.) Citation

Räber, Lorenz, et al. "Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial." JAMA : The Journal of the American Medical Association, vol. 327, no. 18, 2022, p. 1771, https://doi.org/10.1001/jama.2022.5218.